Document
IPR2018-01675, No. 1028-27 Exhibit - Mylan GmbH and Biocon¿¿¿s Preliminary Claim Constructions and Supporting Evidence Pursuant to L Pat R 42, Sanofi Aventis US, LLC v Mylan NV, CA No 1...
Cite Document
IPR2018-01675, No. 1028-27 Exhibit - Mylan GmbH and Biocon¿¿¿s Preliminary Claim Constructions and Supporting Evidence Pursuant to L Pat R 42, Sanofi Aventis US, LLC v Mylan NV, CA No 17 cv 09105 file
+ More Snippets
Document
IPR2018-01675, No. 1043-197 Exhibit - Transcript of Telephone Conference on July 25, 2019 (P.T.A.B. Jul. 29, 2019)
Cite Document
IPR2018-01675, No. 1043-197 Exhibit - Transcript of Telephone Conference on July 25, 2019 (P.T.A.B. Jul. 29, 2019)
+ More Snippets
Document
IPR2018-01675, No. 2193-171 Exhibit - Formulary Placement of Long Acting Insulin Pen Products Medicaid Plans (P.T.A.B. Jun. 25, 2019)
Cite Document
IPR2018-01675, No. 2193-171 Exhibit - Formulary Placement of Long Acting Insulin Pen Products Medicaid Plans (P.T.A.B. Jun. 25, 2019)
+ More Snippets
Document
IPR2018-01675, No. 2190-168 Exhibit - US Share of Sales by Drugs in the Lantus Franchise (P.T.A.B. Jun. 25, 2019)
Cite Document
IPR2018-01675, No. 2190-168 Exhibit - US Share of Sales by Drugs in the Lantus Franchise (P.T.A.B. Jun. 25, 2019)
+ More Snippets
Document
IPR2018-01675, No. 2100-80 Exhibit - Leinsing Deposition Exhibit 2100 Thomas van der Burg, Injection Force of SoloSTAR¿¿ Compared with Other Disposable Insulin Pen Devices at Constant Vo...
Cite Document
IPR2018-01675, No. 2100-80 Exhibit - Leinsing Deposition Exhibit 2100 Thomas van der Burg, Injection Force of SoloSTAR¿¿ Compared with Other Disposable Insulin Pen Devices at Constant Volume Flow Rate
+ More Snippets
Document
IPR2018-01675, No. 2186-164 Exhibit - Select Injectable Insulin Drugs Approved by the FDA in the US (P.T.A.B. Jun. 25, 2019)
Cite Document
IPR2018-01675, No. 2186-164 Exhibit - Select Injectable Insulin Drugs Approved by the FDA in the US (P.T.A.B. Jun. 25, 2019)
+ More Snippets
Document
IPR2018-01675, No. 1019-44 Exhibit - Plaintiffs¿¿¿ Preliminary Claim Constructions and Preliminary Identification of Supporting Intrinsic and Extrinsic Evidence, Sanofi Aventis US LLC v Mylan Gm...
Cite Document
IPR2018-01675, No. 1019-44 Exhibit - Plaintiffs¿¿¿ Preliminary Claim Constructions and Preliminary Identification of Supporting Intrinsic and Extrinsic Evidence, Sanofi Aventis US LLC v Mylan GmbH, No
+ More Snippets
Document
IPR2018-01675, No. 1010-37 Exhibit - File History for US Patent 9,604,008 (P.T.A.B. Sep. 10, 2018)
Cite Document
IPR2018-01675, No. 1010-37 Exhibit - File History for US Patent 9,604,008 (P.T.A.B. Sep. 10, 2018)
+ More Snippets
Document
IPR2018-01675, No. 2104-84 Exhibit - Leinsing Deposition Exhibit 2104 Annotations of Figures 5 8 of the 486 Patent (P.T.A.B. Jun. 25, 2019)
Cite Document
IPR2018-01675, No. 2104-84 Exhibit - Leinsing Deposition Exhibit 2104 Annotations of Figures 5 8 of the 486 Patent (P.T.A.B. Jun. 25, 2019)
+ More Snippets
Document
IPR2018-01675, No. 2143-124 Exhibit - Thomas Haak et al, Comparison of Usability and Patient Preference for the New Disposable Insulin Device SoloStar Versus FlexPen, Lilly Disposable Pen,...
Cite Document
IPR2018-01675, No. 2143-124 Exhibit - Thomas Haak et al, Comparison of Usability and Patient Preference for the New Disposable Insulin Device SoloStar Versus FlexPen, Lilly Disposable Pen, and a Proto
+ More Snippets
Document
IPR2018-01675, No. 2208-185 Exhibit - Press Release, Lantus Apdira SoloSTAR help to improve patient satisfaction June 27, 2011 (P.T.A.B. Jun. 25, 2019)
Cite Document
IPR2018-01675, No. 2208-185 Exhibit - Press Release, Lantus Apdira SoloSTAR help to improve patient satisfaction June 27, 2011 (P.T.A.B. Jun. 25, 2019)
+ More Snippets
Document
IPR2018-01675, No. 2146-128 Exhibit - Lantus COMPASS Study Report Nov 29, 2007, Part Two (P.T.A.B. Jun. 25, 2019)
Cite Document
IPR2018-01675, No. 2146-128 Exhibit - Lantus COMPASS Study Report Nov 29, 2007, Part Two (P.T.A.B. Jun. 25, 2019)
+ More Snippets
Document
IPR2018-01675, No. 2163-141 Exhibit - Deposition of Karl R Leinsing, dated June 3, 2019 for IPR2018 01675, 01676, 01678, 01680 (P.T.A.B. Jun. 25, 2019)
Cite Document
IPR2018-01675, No. 2163-141 Exhibit - Deposition of Karl R Leinsing, dated June 3, 2019 for IPR2018 01675, 01676, 01678, 01680 (P.T.A.B. Jun. 25, 2019)
+ More Snippets
Document
IPR2018-01675, No. 2159-137 Exhibit - Serpil Savas et al, The effects of the diabetes related soft tissue hand lesions and the reduced hand strength on functional disability of hand in type 2 diab...
Cite Document
IPR2018-01675, No. 2159-137 Exhibit - Serpil Savas et al, The effects of the diabetes related soft tissue hand lesions and the reduced hand strength on functional disability of hand in type 2 diabetic
+ More Snippets
Document
IPR2018-01675, No. 2018-66 Exhibit - Letter from A Calmann to Judge Waldor dated Apr 24, 2018,Sanofi Aventis US LLC et al v Mylan NV et al, Case No 217 cv 09105 SRC CLW DNJ, Dkt No 90 (...
Cite Document
IPR2018-01675, No. 2018-66 Exhibit - Letter from A Calmann to Judge Waldor dated Apr 24, 2018,Sanofi Aventis US LLC et al v Mylan NV et al, Case No 217 cv 09105 SRC CLW DNJ, Dkt No 90 (P.T.A.B. Feb. 1
+ More Snippets